Evidence map›Paper›PMID 30220567›Full record

ArticleDevelopmental cell2018

The Ciliary Machinery Is Repurposed for T Cell Immune Synapse Trafficking of LCK.

Louise A Stephen, Yasmin ElMaghloob, Michael J McIlwraith, Tamas Yelland, Patricia Castro Sanchez, Pedro Roda-Navarro, Shehab Ismail

Open access · hybridAbstract read
In one paragraph

Article in Developmental cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 48 citations in OpenAlex.

  1. T-betThe FEBS journal · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. BMP-ACVR1 Axis is Critical for Efficacy of PRC2 Inhibitors in B-Cell Lymphoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  9. Article
  10. Patterns of Ciliation and Ciliary Signaling in Cancer.Reviews of physiology, biochemistry and pharmacology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Louise A StephenCR-UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Yasmin ElMaghloobCR-UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Michael J McIlwraithCR-UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Tamas YellandCR-UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Patricia Castro SanchezDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain; 12 de Octubre Health Research Institute (imas12), Madrid 28040, Spain.
Pedro Roda-NavarroDepartment of Immunology, School of Medicine, Universidad Complutense de Madrid, Madrid 28040, Spain; 12 de Octubre Health Research Institute (imas12), Madrid 28040, Spain.
Shehab IsmailCR-UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow G12 8QQ, UK. Electronic address: s.ismail@beatson.gla.ac.uk.
University of Glasgow · GBResearch Institute Hospital 12 de Octubre · ESUniversidad Complutense de Madrid · ES

Funding

Cancer Research UK 19257Cancer Research UK A19257
6 · The paper itself

Abstract

Upon engagement of the T cell receptor with an antigen-presenting cell, LCK initiates TCR signaling by phosphorylating its activation motifs. However, the mechanism of LCK activation specifically at the immune synapse is a major question. We show that phosphorylation of the LCK activating Y394, despite modestly increasing its catalytic rate, dramatically focuses LCK localization to the immune synapse. We describe a trafficking mechanism whereby UNC119A extracts membrane-bound LCK by sequestering the hydrophobic myristoyl group, followed by release at the target membrane under the control of the ciliary ARL3/ARL13B. The UNC119A N terminus acts as a "regulatory arm" by binding the LCK kinase domain, an interaction inhibited by LCK Y394 phosphorylation, thus together with the ARL3/ARL13B machinery ensuring immune synapse focusing of active LCK. We propose that the ciliary machinery has been repurposed by T cells to generate and maintain polarized segregation of signals such as activated LCK at the immune synapse.

Indexed as

Adaptor Proteins, Signal TransducingADP-Ribosylation FactorsAntigen-Presenting CellsCiliaHumansImmunological SynapsesJurkat CellsLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)PhosphorylationProtein TransportReceptors, Antigen, T-CellSignal TransductionAdaptor Proteins, Signal TransducingADP-Ribosylation FactorsARL3 protein, humanLymphocyte Specific Protein Tyrosine Kinase p56(lck)Receptors, Antigen, T-CellUNC119 protein, humanARL13BARL3ciliaGDIimmunological synapseLCKprotein traffickingsmall GTPasesSrc kinasesUNC119

Identifiers

PMID30220567
PMCPMC6179904
OpenAlexW2892280916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.